These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 326969)

  • 21. Cellular immunity in natural and experimental infections caused by Mycobacterium tuberculosis and Mycobacterium kansasii.
    Kubín M
    Czech Med; 1980; 3(2):138-43. PubMed ID: 6774866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage migration inhibition as an in vitro correlate of cutaneous delayed skin reaction. II. Investigations on BCG vaccinated guinea pigs.
    Rédei A; Keserü G; Frigyesi A
    Acta Microbiol Acad Sci Hung; 1973; 20(4):275-81. PubMed ID: 4794976
    [No Abstract]   [Full Text] [Related]  

  • 23. Tuberculin-active carbohydrate that induces inhibition of macrophage migration but not lymphocyte transformation.
    Chaparas SD; Thor DE; Godfrey HP; Baer H; Hedrick SR
    Science; 1970 Nov; 170(3958):637-9. PubMed ID: 4919183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ELISA method for quantitation of macrophage migration from agarose microdroplets.
    Peck R
    J Immunol Methods; 1983 Nov; 64(1-2):179-87. PubMed ID: 6358361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of Lotus-tetragonolobus Lectin (LTL) and an MIF-like factor with guinea-pig macrophages. I. Effects on macrophage migration inhibition and receptor-binding studies.
    Fahlbusch B; Wollweber L; Drössler K; Scherbaum I; Zschiesche W
    Immunobiology; 1982 Aug; 162(3):251-64. PubMed ID: 6752005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental studies of tumor immunotherapy. I. Macrophage migration inhibitory activity as an immunological parameter.
    Hayashi S
    Acta Med Okayama; 1976 Apr; 30(2):95-106. PubMed ID: 135489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A possible relationship between delayed hypersensitivity and cell-mediated immunity.
    Salvin SB; Neta R
    Am Rev Respir Dis; 1975 Apr; 111(4):373-7. PubMed ID: 47728
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage.
    Leu RW; Eddleston AL; Hadden JW; Good RA
    J Exp Med; 1972 Sep; 136(3):589-603. PubMed ID: 4115133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of the macrophage migration inhibition test for in vitro titration of tuberculins.
    Nyabenda J; Bendeck JG
    J Biol Stand; 1985 Oct; 13(4):345-53. PubMed ID: 3902843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of the migration of mouse lymphoid cells by BCG: a factor stimulating T-cell migration.
    Castes M; Borderie N; Orbach-Arbouys S
    Cell Immunol; 1978 Sep; 40(1):37-45. PubMed ID: 359172
    [No Abstract]   [Full Text] [Related]  

  • 31. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
    Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
    J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 33. A leukocyte migration inhibition assay technique using blood clot fragments in vitro.
    Sandru G
    Eur J Immunol; 1975 Oct; 5(10):729-31. PubMed ID: 11993343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
    Klimpel GR; Okada M; Henney CS
    J Immunol; 1979 Jul; 123(1):350-7. PubMed ID: 156233
    [No Abstract]   [Full Text] [Related]  

  • 35. Lotus tetragonolobus fucolectin as a potential model for "MIF-like" modulation of macrophage function: comparison of the interaction of Lotus fucose binding protein (FBP) and migration inhibitory factor (MIF) with macrophages in the migration inhibition assay.
    Leu RW; Whitley SB; Herriott J; Huddleston DJ
    Cell Immunol; 1980 Jul; 52(2):414-28. PubMed ID: 7002321
    [No Abstract]   [Full Text] [Related]  

  • 36. Release of superoxide and hydrogen peroxide from guinea-pig alveolar macrophages during phagocytosis of Mycobacterium bovis BCG.
    Jackett PS; Andrew PW; Lowrie DB
    Adv Exp Med Biol; 1982; 155():687-93. PubMed ID: 6297271
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental studies of tumor immunotherapy. II. Tumor immunotherapy following tumor extirpation.
    Hayashi S
    Acta Med Okayama; 1976 Jun; 30(3):197-208. PubMed ID: 136871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determining hypersensitivity to antigens by computing cells migrating from capillary tubes].
    Novikov DK; Adamenko GP; Novikova VI
    Biull Eksp Biol Med; 1976 Jun; 81(6):707-10. PubMed ID: 953309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new assay for rapid measurement of MIF levels by 3H-labelled cells in liquid scintillation counting vials: statistical implications for the measurement of migration inhibition.
    McDaniel MC; Robbins CH; Hokanson JA; Papermaster BW
    J Immunol Methods; 1978; 20():225-39. PubMed ID: 349080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Migration of natural suppressor cells from bone marrow to peritoneal cavity by live BCG.
    Kato K; Yamamoto K; Kimura T
    J Immunol; 1985 Dec; 135(6):3661-8. PubMed ID: 2933452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.